Skip to content

Effect of epidural dexmedetomidine combined with ropivacaine in labor analgesia: a randomized double-blinded controlled study

Effect of epidural dexmedetomidine combined with ropivacaine in labor analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007263
Enrollment
Unknown
Registered
2015-10-21
Start date
2015-10-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labor analgesia

Interventions

Sponsors

the Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 35 Years

Inclusion criteria

Inclusion criteria: healthy (ASA I, II), 22-35-year-old nulliparous parturient women, who had the intention to deliverbaginally, in active stage of labor with singleton foetus in vertex presentation without systemic analgesic administration.

Exclusion criteria

Exclusion criteria: 1. Maternal risk factors for which to consider neuraxial labor analgesia( morbid obesity, severe preeclampsia, fetal macrosomia, multiple gestation, nonreassuring airway examination, high risk for operative delivery, prior hisory of anesthesia complications); 2. Absolute contraindications or relative contraindications to neuraxial anesthesia and analgesia (patient refusal, infection at the site of injection, coagulopathy, uncorrected hypovolemia, increased intracranial pressure, severe cardiac valvular stenosis, allergy to local anesthetic, inadequate resuscitative drugs or equipment immediately available, uncooperative patient, preexisting neurologic deficits, infection distant to the site of injection, spinal deformity or previous spinal surgery, thrombocytopenia).

Design outcomes

Primary

MeasureTime frame
VAS scores;

Countries

China

Contacts

Public ContactYingzhi Liu
qdyingzhiliu@sina.com+86 13789692629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026